Offstream
news

According to government data, more than 473 million people have received at least one dose of a COVID-19 vaccine, which amounts to about half of all eligible adults in India. However, only around 15% of eligible adults have been fully vaccinated against COVID-19.
2021-08-27

The Indian government approves the emergency use of the ZyCoV-D vaccine made by Cadila Healthcare, which is the world's first three-dose DNA-based COVID-19 vaccine.
2021-08-20

Nepal begins administering second doses of the Oxford-AstraZeneca vaccine dose for nearly 1.4 million elderly people following a months-long delay due to India suspending exports of vaccines due to a substantial increase in the number of cases there. The vaccines were donated by Japan and Bhutan.
2021-08-9

Phase-III trials of the Covaxin vaccine from India's Bharat Biotech showed a 65.2% efficacy against the Delta variant, a 77.8% efficacy against symptomatic COVID-19, and a 93.4% efficacy against severe COVID-19.
2021-07-3

India reports a new single-day record of 3.67 million doses of the COVID-19 vaccine administered.
2021-04-2

Brazil's health regulator Anvisa said Bharat Biotech's Covaxin did not meet its manufacturing standards. The Brazilian government previously signed a contract to buy 20 million doses. Bharat said in a statement that they would appeal the decision.
2021-03-30

Bhutan launches their largest vaccination campaign against COVID-19 using the Oxford-AstraZeneca vaccine that was received from India.
2021-03-27

Zimbabwe grants emergency use authorization for four COVID-19 vaccines, including China's CoronaVac and BBIBP-CorV, Russia's Sputnik V, and India's Covaxin.
2021-03-9

Zimbabwe becomes the first country in Africa to approve India's Covaxin vaccine manufactured by Bharat Biotech.
2021-03-4

Mexico receives a shipment of 870,000 doses of the Oxford–AstraZeneca vaccine from India.
2021-02-14